Zhiyuan Xu

2 months ago | mdpi.com | Zhiyuan Xu |Ming Cheng

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Sep 17, 2024 | dx.doi.org | Liu Xiao |Zhiyuan Xu |Huan Li

Mar 10, 2024 | arxiv.org | Yichen Zhu |Xin A. Liu |Ning Liu |Zhiyuan Xu

Jan 5, 2024 | arxiv.org | Yichen Zhu |Minjie Zhu |Jinming Li |Zhiyuan Xu

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Feb 9, 2023 | frontiersin.org | Zhiyuan Xu |Fang Fang

Kuanyu Wang1,2, Dezhi Gao1,2, Jian Pan1,2, Enmeng Bao1,2 and Shibin Sun1,2*1Gamma Knife Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China2Gamma Knife Center, Beijing Neurosurgical Institute, Capital Medical University, Beijing, ChinaObjective: Chordoma is a slow-growing and locally aggressive cancer, which arises from the remnants of the primitive notochord. The first line treatment for the skull base chordoma is neurosurgery.